THIS WARRANT AND THE SHARES ISSUABLE UPON THE EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. EXCEPT AS OTHERWISE SET FORTH HEREIN NEITHER THIS WARRANT NOR ANY OF SUCH SHARES MAY BE SOLD, TRANSFERRED OR...DanDrit Biotech USA, Inc. • February 9th, 2018 • Pharmaceutical preparations • Delaware
Company FiledFebruary 9th, 2018 Industry JurisdictionTHIS Common Stock Purchase Warrant CERTIFIES THAT, for value received, ____________ or his registered assigns (“Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 PM Eastern Standard Time on December 31, 2019 (the “Expiration Date”) but not thereafter, to subscribe for and purchase from DanDrit Biotech USA, Inc., a Delaware corporation with offices at Stumpedyssevej 17, 2970 Hørsholm, Denmark (the “Company”) an aggregate of up to 300,000 shares of common stock, par value $0.0001 per share, of the Company (the “Shares”), at an initial price per Share of $2.00, as adjusted in accordance with Section 2 below (the “Purchase Price”).
THIS WARRANT AND THE SHARES ISSUABLE UPON THE EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. EXCEPT AS OTHERWISE SET FORTH HEREIN NEITHER THIS WARRANT NOR ANY OF SUCH SHARES MAY BE SOLD, TRANSFERRED OR...DanDrit Biotech USA, Inc. • May 1st, 2017 • Pharmaceutical preparations • Delaware
Company FiledMay 1st, 2017 Industry JurisdictionTHIS Common Stock Purchase Warrant CERTIFIES THAT, for value received, [_______________], or its registered assigns, (“Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 PM Eastern Standard Time on [_______________] (the “Expiration Date”) but not thereafter, to subscribe for and purchase from DanDrit Biotech USA, Inc., a Delaware corporation with offices at Fruebjergvej 3 Box 62, 2100 Copenhagen, Denmark (the “Company”) an aggregate of up to [________] shares of common stock, par value $0.0001 per share, of the Company (the “Shares”), at a price per Share specified herein, as adjusted in accordance with Section 2 below (the “Purchase Price”).
Series B Common Stock Purchase Warrant issued by Two Rivers Water CompanyTWO RIVERS WATER Co • September 21st, 2011 • Agricultural production-crops
Company FiledSeptember 21st, 2011 IndustryThis Common Stock Purchase Warrant (this “Warrant”) certifies that, for value received, ______________________________________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 PM Mountain Standard Time on December 31, 2012 (the “Expiration Date”) but not thereafter, to subscribe for and purchase from Two Rivers Water Company(the "Company"), a Colorado corporation, having its principal executive offices at 2000 Colorado Boulevard, Annex Suite 420, Denver, Colorado 80222, up to 400,000 shares (the “Shares”)of the Company's common stock, par value $.001 per share(the "Common Stock") at a price of $2.50 per Share, as adjusted in accordance with Section 2 below (the "Purchase Price").
LIQTECH USA, INC. COMMON STOCK PURCHASE WARRANTBlue Moose Media Inc • August 25th, 2011 • Blank checks • Delaware
Company FiledAugust 25th, 2011 Industry JurisdictionThis Common Stock Purchase Warrant (this “Warrant”) certifies that, for value received, ___________________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 PM Eastern Standard Time on December 31, 2016 (the “Expiration Date”) but not thereafter, to subscribe for and purchase from Liqtech USA, Inc. (the "Company"), a Delaware corporation, having its principal place of business at 888 Seventh Avenue, New York, NY 10106, up to ______________ shares (the “Shares”)of the Company's common stock, par value $.001 per share (the "Common Stock") at a price of $1,500 per Share, as adjusted in accordance with Section 2 below (the "Purchase Price").